U.S. Software Stock News

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...

IDEXX Laboratories (NasdaqGS:IDXX) announced the upcoming retirement of long-serving Board member M. Anne Szostak. The company also disclosed the appointment of Michael G. Erickson, PhD, to its Board of Directors. These Board changes reflect an ongoing refresh of corporate governance and Board composition. IDEXX Laboratories focuses on diagnostic and software solutions for veterinary practices, livestock, poultry, and water testing, placing the company at the center of long term trends in...

In February 2026, Aspen Aerogels reported fourth-quarter 2025 sales of US$41.34 million versus US$123.09 million a year earlier, swung to a net loss of US$72.91 million, recorded an impairment charge on property, plant and equipment, and launched a broad review of options for its business and capital structure. An important insight is that management characterizes this strategic review as coming from a position of financial strength and operational progress, even as the company posts a...

Central Securities Corporation (NYSE American: CET) has released its annual report for the year ended December 31, 2025, reporting full-year net income of US$265.21 million. The annual report gives investors a clearer view into how this closed-end investment company managed its portfolio and operations over the 2025 calendar year. We will now examine how Central Securities’ 2025 net income performance shapes the company’s investment narrative for shareholders and prospective...

Nvidia (NVDA) has put up big headline numbers for FY 2026, with fourth quarter revenue of about US$68.1b and basic EPS of US$1.77, capping a year in which trailing 12 month EPS reached US$4.93 alongside revenue of roughly US$215.9b. Over the past six quarters, the company has seen quarterly revenue move from about US$35.1b with EPS of US$0.79 in FY 2025 Q3 to US$68.1b and EPS of US$1.77 in FY 2026 Q4. This sets up a story where investors are watching how rich margins and strong earnings...

Wondering whether Plug Power's share price around US$1.91 is starting to look like value, or if it still carries more risk than upside? You are not alone in asking that question right now. The stock has been flat over the last 7 days, while the 30 day return is a 20.7% decline, set against a 17.2% gain over 1 year and much weaker 3 and 5 year returns of 85.7% and 95.2% declines. Recent news flow has focused on Plug Power's position in hydrogen and fuel cell markets, as investors weigh long...

Garrett Motion (NasdaqGS:GTX) agreed to supply its oil free centrifugal compressor to Cling for use in China's next generation electric buses and trucks. The deal represents Garrett Motion's first serial award for its oil free, foil bearing based centrifugal compressor within the mobility sector. The compressor is intended to support advanced HVAC systems that focus on energy efficiency, compact size, reduced noise, and durability for commercial EVs in China. Garrett Motion, best known for...

If you are wondering whether Seacoast Banking Corporation of Florida is currently priced attractively, you are not alone. The stock has drawn interest from investors trying to work out if today’s share price lines up with its fundamentals. Over the past year, the share price return sits at 21.0%, with a 4.1% gain year to date. This comes even though the last 7 and 30 days have seen modest pullbacks of 1.8% and 2.2% respectively from the recent close at US$32.90. Recent coverage of regional...

If you are wondering whether TriCo Bancshares is fairly priced or offering value at its recent levels, this article will walk you through what the numbers actually say about the stock. The share price last closed at US$49.77, with returns of a 0.9% decline over 7 days, 1.4% over 30 days, 5.6% year to date, 18.6% over 1 year and 26.7% over 5 years. This naturally raises questions about how much is already reflected in the price and how much risk is being priced in. Recent coverage of TriCo...

Urban Outfitters FY 2026 results: steady revenue and earnings backdrop Urban Outfitters (URBN) has just wrapped up FY 2026 with fourth quarter revenue of US$1.8 billion, basic EPS of US$1.07 and net income of US$96.3 million, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$1.53 billion in Q3 FY 2026 to US$1.8 billion in Q4, while basic EPS shifted from US$1.30 to US$1.07 over the same stretch, and trailing twelve month EPS...

If you are wondering whether Carter's current share price offers value or potential risk, starting with the recent share performance and valuation checks can give you a clearer picture. Carter's shares last closed at US$42.07, with returns of 0.1% over 7 days, 20.7% over 30 days, 26.7% year to date, 4.4% over 1 year, along with 36.1% and 38.8% declines over 3 and 5 years respectively. Recent news coverage has focused on Carter's positioning in the childrenswear market and investor interest...

SkyWater Technology (SKYT) Posts Mixed FY 2025 Finish With Big Q3 EPS Spike and Q4 Loss SkyWater Technology (SKYT) closed out FY 2025 with Q4 revenue of US$171.0 million and a basic EPS loss of US$0.16, following a Q3 that featured US$150.7 million in revenue and a sharp basic EPS jump to US$2.98 on net income of US$144.0 million. Over recent periods the company has seen quarterly revenue move from US$75.5 million in Q4 2024 to US$61.3 million in Q1 2025, US$59.1 million in Q2 2025, and then...

ON24 (ONTF) has wrapped up FY 2025 with fourth quarter revenue of US$34.6 million and a basic EPS loss of US$0.15, as net income excluding extra items came in at a loss of US$6.5 million. Over recent quarters the company has seen revenue hold in a tight band between US$34.6 million and US$36.7 million, while quarterly basic EPS losses have ranged from US$0.15 to US$0.27 over the periods shown. This gives investors a clearer view of how top line scale lines up against persistent losses. With...

ADT (NYSE:ADT) has acquired Origin AI, a company focused on camera free AI presence sensing technology. The deal includes Origin AI's patent portfolio and will be integrated into ADT's smart home security platform. ADT has also signed a long term commercial agreement with Verisure to bring this AI sensing technology to Europe and Latin America. For investors watching NYSE:ADT at a share price of $8.11, this move signals a push to differentiate its smart home offering with AI driven presence...

Hormel Foods (HRL) opened fiscal Q1 2026 with revenue of about US$3.0 billion and basic EPS of US$0.33, setting a clear snapshot of where the business stands as earnings season gets underway. The company has seen quarterly revenue move in a tight band around US$3.0 billion over the past year, while basic EPS has ranged from a loss of roughly US$0.10 in Q4 2025 to US$0.40 in Q4 2024. This gives investors a mixed but data rich backdrop for judging this quarter. With trailing net profit margin...

TWFG (TWFG) has just posted its FY 2025 numbers, with Q4 revenue at US$68.8 million and basic EPS of US$0.18. This caps off a trailing twelve month profile that includes revenue of US$247.1 million and basic EPS of US$0.51 alongside reported earnings growth of 179.5% over the past year. The company has seen revenue rise from US$49.5 million in Q4 2024 to US$68.8 million in Q4 2025, while quarterly EPS has moved from US$0.11 to US$0.18. This sets the backdrop for analyst forecasts that point...

Snowflake (SNOW) just closed out FY 2026 with fourth quarter revenue of US$1.3 billion and a basic EPS loss of US$0.90, alongside net income excluding extra items of a US$309.6 million loss. Over recent periods the company has seen quarterly revenue move from US$986.8 million in Q4 FY 2025 through US$942.1 million and US$1.0 billion to US$1.1 billion and US$1.2 billion before reaching US$1.3 billion, while basic EPS losses ranged between about US$0.86 and US$1.29 per share. The headline story...

Latest FY 2025 Earnings Snapshot Catalyst Pharmaceuticals (CPRX) just wrapped up FY 2025 with Q4 revenue of US$152.6 million and basic EPS of US$0.43, alongside net income of US$52.7 million, putting concrete numbers around its latest earnings season update. The company has seen quarterly revenue move from US$141.8 million in Q4 2024 to US$152.6 million in Q4 2025, while basic EPS shifted from US$0.47 to about US$0.43 over the same periods. Trailing twelve month EPS stands at US$1.75 and...

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...

Enovix (ENVX) closed FY 2025 with Q4 revenue of US$11.3 million, a basic EPS loss of US$0.16 and a net income loss of US$35.0 million. Over recent quarters the company has seen revenue move from US$9.7 million in Q4 2024 to US$11.3 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.16. This sets the stage for investors to focus on how quickly margins might tighten or widen from here. See our full analysis for Enovix. With the headline numbers on the...

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...

Eos Energy Enterprises (EOSE) just released its FY 2025 numbers with Q4 revenue at US$58.0 million and basic EPS of US$4.19, while the latest trailing twelve month figures show revenue of US$114.2 million and a basic EPS loss of US$0.75. The company has seen quarterly revenue move from US$7.3 million and a basic EPS loss of US$2.20 in Q4 2024 to US$58.0 million and basic EPS of US$4.19 in Q4 2025, with trailing twelve month net income at a US$194.5 million loss. These figures are shaping how...

If you are wondering whether Victoria's Secret shares still offer value after a strong run, the key is to look past the headlines and focus on what the current price really implies. The stock most recently closed at US$65.75, with returns of 7.2% over 7 days, 17.6% over 30 days, 23.2% year to date, 144.7% over 1 year and 74.2% over 3 years. Recent attention around Victoria's Secret has centered on its position in the US retail space and how investors view its brand and store footprint. This...

Donaldson (DCI) just posted its Q2 2026 scorecard, with revenue of US$896.3 million and basic EPS of US$0.80, set against trailing twelve month revenue of US$3.8 billion and EPS of US$3.24 that frame the latest quarter in a broader run of results. Over recent quarters, revenue has moved between US$870 million and US$980.7 million while quarterly EPS has ranged from US$0.49 to just under US$0.99, giving investors a clearer view of how the current print sits within the recent earnings pattern...